These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24384114)

  • 1. Novel therapeutics in multiple sclerosis management: clinical applications.
    Leist T; Hunter SF; Kantor D; Markowitz C
    Am J Med; 2014 Jan; 127(1):S2. PubMed ID: 24384114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic decision making in a new drug era in multiple sclerosis.
    Keegan BM
    Semin Neurol; 2013 Feb; 33(1):5-12. PubMed ID: 23709208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.
    Berger JR
    Am J Manag Care; 2011 May; 17 Suppl 5 Improving():S146-53. PubMed ID: 21761953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future disease-modifying therapies in multiple sclerosis.
    Lim SY; Constantinescu CS
    Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and emerging disease modifying therapies for multiple sclerosis.
    Saidha S; Eckstein C; Calabresi PA
    Ann N Y Acad Sci; 2012 Jan; 1247():117-37. PubMed ID: 22224673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapies in multiple sclerosis.
    Farrell R; Heaney D; Giovannoni G
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):797-816. PubMed ID: 16262563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging oral agents for multiple sclerosis.
    Fox EJ
    Am J Manag Care; 2010 Sep; 16(8 Suppl):S219-26. PubMed ID: 20873946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
    Happe LE
    Am J Manag Care; 2013 Nov; 19(17 Suppl):s332-42. PubMed ID: 24494634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: new insights in pathogenesis and novel therapeutics.
    Ontaneda D; Hyland M; Cohen JA
    Annu Rev Med; 2012; 63():389-404. PubMed ID: 21888515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glatiramer in the treatment of multiple sclerosis.
    Rizvi SA; Kim E; Moodie J
    Int J Nanomedicine; 2006; 1(3):283-9. PubMed ID: 17717969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New options for early treatment of multiple sclerosis.
    Tintoré M
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple sclerosis: can therapy delay ongoing disability?].
    Havla J; Pellkofer HL; Hohlfeld R; Kümpfel T
    MMW Fortschr Med; 2011 Apr; 153(14):63-6. PubMed ID: 21966873
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicine.
    Wiese MD; Suppiah V; O'Doherty C
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1145-59. PubMed ID: 24910969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH; Javed A
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a therapeutic plan for treating MS: evidence for new treatments.
    Levin MC; Jackson WC
    J Clin Psychiatry; 2014 Dec; 75(12):e34. PubMed ID: 25551246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of current and emerging therapeutic strategies in multiple sclerosis.
    Tullman MJ
    Am J Manag Care; 2013 Feb; 19(2 Suppl):S21-7. PubMed ID: 23544717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.